![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Dexcom Sues InSpark Technologies Over Glucose Patents, Claims Non-infringement
Dexcom Sues InSpark Technologies Over Glucose Patents, Claims Non-infringement
Dexcom has filed a suit against InSpark Technologies, claiming it did not infringe on three patents related to glucose-monitoring technology.
InSpark Technologies holds the three patents in dispute that concern the methods for evaluating and monitoring glucose.
Dexcom is requesting a declaratory judgment of non-infringement for ’703 patent, ’985 patent and ’425 patent concerning its Dexcom Clarity software. — José Vasquez
Upcoming Events
-
21Oct